Novel Outcome Measures for Clinical Trials in Cystic Fibrosis

Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF transmembrane regulator protein. With increased understanding of the molecular mechanisms underlying CF and the development of new therapies there comes the need to develop new outcome measures to as...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatr Pulmonol
Hlavní autoři: Tiddens, Harm AWM, Puderbach, Michael, Venegas, Jose G, Ratjen, Felix, Donaldson, Scott H, Davis, Stephanie D, Rowe, Steven M, Sagel, Scott D, Higgins, Mark, Waltz, David A
Médium: Artigo
Jazyk:Inglês
Vydáno: BlackWell Publishing Ltd 2015
Témata:
Reviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4365726/
https://ncbi.nlm.nih.gov/pubmed/25641878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.23146
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky